Veselibas un socialas aprupes klinika APS SIA
- Address
- Lastadijas Iela 40, 1050 Riga, Latvia
Cardiovascular Diseases
At Veselibas un socialas aprupes klinika APS SIA in Riga, clinical research in cardiovascular diseases focuses on atrial fibrillation and chronic heart failure. These studies are designed to help prevent serious complications, improve heart-related outcomes, and better understand treatment effectiveness and safety.
- Prevention of stroke and systemic embolism in people with atrial fibrillation
- Reducing cardiovascular mortality and hospitalizations in symptomatic chronic heart failure
- Evaluating new approaches to improve the balance between benefit and bleeding risk
This work reflects a strong interest in identifying better options for patients at risk of clot-related events and worsening heart failure.
Immune System Diseases
Research in immune system diseases at this site is centered on Graves’ disease, an autoimmune condition that affects thyroid function. The trials are aimed at assessing whether new treatment strategies can help restore and maintain normal hormone levels while supporting longer-term disease control.
- Studying treatment effects on thyroid hormone levels and related disease markers
- Assessing whether patients can maintain euthyroidism over time
- Exploring improved management of autoimmune thyroid disease
These studies contribute to a broader effort to improve care for people living with Graves’ disease through more effective and durable treatment options.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Immunovant Sciences GmbH2active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Immunovant Sciences GmbH2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 80 other sites in Latvia
Therapeutic Area Benchmark — Latvia
Select a therapeutic area to compare against other sites in Latvia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Latvia
Market Share
Country: Latvia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Veselibas un socialas aprupes klinika APS SIA
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Randomized Study of IMVT-1402 Versus Placebo in Adult Patients with Graves' Disease | Immunovant Sciences GmbH | Phase II | Recruiting | Nov 2025 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| IMEROPRUBART | 2 | Unknown | 2025-11-21 | 2026-05-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.